Skip to main content
. 2019 Oct 26;11(11):1660. doi: 10.3390/cancers11111660
AML Acute Myeloid Leukaemia
MDS Myelodysplastic Syndrome
7+3 7 days of cytarabine and days of an anthracycline
FLAG Fludarabine, Cytarabine, Granulocyte Colony Stimulating Factor
FLAG-IDA Fludarabine, Cytarabine, Granulocyte Colony Stimulating Factor and Idarubicin
HMA Hypomethylating agent
LDAC Low dose Ara-C
BCL-2 B cell lymphoma 2
BCL-xL B cell lymphoma extra large
MCL-1 Myeloid Leukemia Cell Differentiation Protein
FLT3 Fms like tyrosine kinase 3
NPM1 Nucleophosmin
IDH1/2 Isocitrate Dehydrogenase 1/2
CR Complete Remissiob
CRi Complete remission with incomplete haematological recovery
PR Partial Remission
R/R Relapsed and Refractory